Charles River Laboratories | CRL - 流動負債





流動負債 変化する 日付
Agilent USD 2.29B 20M 2026-06
Align Technology USD 1.91B 4.9M 2026-09
Bio-Rad Laboratories USD 969.1M 7.8M 2026-09
Bruker USD 1.17B 32.6M 2026-09
Cardinal Health USD 46.33B 2.42B 2026-09
Charles River Laboratories USD 1.09B 45.49M 2026-09
Cigna USD 56.03B 471M 2026-09
Concord Medical Services Hldg CNY 1.95B 499.89M 2025-12
CVS Health USD 93.1B 6.06B 2026-09
Danaher USD 9.05B 945M 2026-09
Dentsply International USD 1.22B 32M 2026-09
Elevance Health USD 46.66B 2.41B 2026-09
Humana USD 24.05B 1.05B 2026-09
Illumina USD 1.16B 422M 2026-09
Incyte USD 1.44B 125.72M 2026-09
Intrexon USD 23.02M 38K 2024-06
IQVIA Holdings USD 7.78B 1.04B 2026-09
Laboratory Of America USD 2.82B 695M 2026-09
Lakefront Biotherapeutics EUR 70.32M 30.1M 2026-06
Lonza CHF 3.57B 421M 2025-12
McKesson USD 74.4B 4.04B 2026-09
Merck EUR 8.12B 1.22B 2026-06
Mettler Toledo International USD 1.25B 49.81M 2026-09
Novartis USD 32.52B 777M 2026-09
Pfizer USD 31.73B 920M 2026-09
Quest Diagnostics USD 1.83B 46M 2026-09
Revvity USD 701.48M 574.88M 2026-09
Thermo Fisher Scientific USD 14.17B 899M 2026-09
United Therapeutics USD 624.3M 16.5M 2026-09
UnitedHealth USD 115.84B 4.02B 2026-09
Veradigm USD 230.31M 22.78M 2022-12
Waters USD 2.4B 126M 2026-06
West Pharmaceutical Services USD 644.3M 3.8M 2026-09